Advertisement

Topics

Crack Open the Champagne, AiCuris’ Antiviral Gets FDA Approval

06:57 EST 9 Nov 2017 | Labiotech.eu

AiCuris will be jumping for joy after its Human Cytomegalovirus (HCMV) treatment, letermovir, was approved by the FDA. AiCuris develops antiviral and antibacterial agents to treat life-threatening infectious diseases. Today, the company and its partner, Merck Sharp & Dohme (MSD), will revel in the ...

This awesome article Crack Open the Champagne, AiCuris’ Antiviral Gets FDA Approval appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Crack Open the Champagne, AiCuris’ Antiviral Gets FDA Approval

NEXT ARTICLE

More From BioPortfolio on "Crack Open the Champagne, AiCuris’ Antiviral Gets FDA Approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...